Vitamin E therapy in retinopathy of prematurity

D P Muller1

  • 1Institute of Child Health, London.

Eye (London, England)
|January 1, 1992
PubMed

Insights

Vitamin E, an antioxidant, may help premature infants

Area of Science:

  • Neonatal medicine
  • Ophthalmology
  • Nutritional science

Background:

  • Premature infants are vulnerable to oxidative stress.
  • Retinopathy of prematurity (ROP) is a serious condition affecting premature infants' eyes.
  • Vitamin E is a known antioxidant that scavenges free radicals.

Purpose of the Study:

  • To critically review the use of vitamin E for retinopathy of prematurity (ROP).
  • To evaluate the risk-benefit relationship of prophylactic vitamin E in premature infants.

Main Methods:

  • Literature review of existing trials on vitamin E and ROP.
  • Analysis of the evidence regarding prophylactic vitamin E supplementation.
  • Assessment of the safety and efficacy of vitamin E in this population.

Main Results:

  • The role of prophylactic vitamin E in ROP management remains controversial.
  • Evidence supporting its routine use is inconclusive despite numerous studies.
  • The risk-benefit profile requires careful consideration.

Conclusions:

  • Prophylactic vitamin E supplementation for ROP is not definitively established.
  • Further research may be needed to clarify its role.
  • Clinical decisions should weigh potential benefits against risks in premature infants.